238MO PROMENADE: PembROlizuMab for early triple negative ER-low breast caNcer, reAl worlD frEnch cohort.
Saved in:
| Title: | 238MO PROMENADE: PembROlizuMab for early triple negative ER-low breast caNcer, reAl worlD frEnch cohort. |
|---|---|
| Authors: | Cherifi, F.1 (AUTHOR), Cabel, L.2 (AUTHOR), Bousrih, C.3 (AUTHOR), Volant, E.4 (AUTHOR), Dalenc, F.5 (AUTHOR), Mery, B.6 (AUTHOR), Kuentz, M. Auvray7 (AUTHOR), Alexandre, M.8 (AUTHOR), Benistant, L.9 (AUTHOR), Leheurteur, M.10 (AUTHOR), Bailleux, C.11 (AUTHOR), Debled, M.12 (AUTHOR), Frenel, J-S.13 (AUTHOR), Loirat, D.2 (AUTHOR), Bidard, F.C.2 (AUTHOR), Aho, S.14 (AUTHOR), Glenet, A.15 (AUTHOR), Mourato, J.T.L. Ribeiro16 (AUTHOR), Christy, F.17 (AUTHOR), Emile, G.18 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS312-S313. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.181 |
